Completed
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants
NCT02337751
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Matsuyama, Ehime, Japan
- Tōon, Ehime, Japan
- Kitakyushu, Fukuoka, Japan